Nitin Naik | Vice President-Global Life Sciences
Frost and Sullivan

Functional Expertise
Close to 20 years of healthcare industry knowledge, including 10 plus years of consulting expertise focusing on the pharmaceutical and biotechnology sector. Adept at leading cross-functional teams and building top management support for strategic initiatives such as:
-New market and therapeutic area analysis
-Sales, Marketing and business planning
-Global Alliances, Public Private Partnerships, M&A. Industry Expertise

Industry Experience

• Experience base covering key healthcare sectors from pharmaceuticals and biotechnology to clinical diagnostics and clinical research. Expertise in Translational R&D (Biologics & Small molecules) , Oncology (Brain Tumors; Breast & Prostate Cancer), Antimicrobials (Nanopolymers, Peptides and Quorum Sensing compounds), In-vitro Toxicology
• Executed deals with highly specialized contract issues regarding co-innovation programs, research collaborations and licensing agreements.
• Conducted market entry, distribution and sales and marketing strategy across various healthcare areas What I bring to the Team

• Detailed industry and therapeutic area expertise, including knowledge of key emerging and established markets from a market, regulatory and reimbursement point of view
• In-depth understanding of healthcare markets across the world from government healthcare structures and policy to end user and market evaluations. Ability to guide companies on adoption of methodologies and designs to suit individualized specifications and needs. Career Highlights

• Spent 5-10 years each with GE Healthcare (national distributor), Frost & Sullivan Asia & A*STAR Singapore in various roles from strategy, marketing to in-licensing, portfolio management and market planning. Facilitated several regional and global strategic alliances
• At Frost & Sullivan Asia , established a responsive, multi-million dollar consulting business unit .Tripled revenues for Japan business in 2 years
• At A*STAR, developed and executed #1 business transformation initiative leading to launch of Diagnostics(DxD) and Biopharma Manufacturing Hubs . Received Excellence Award from Taiwan Biotech Industry Association for chairing a high level CEO/ministerial growth workshop to design the 5 year national strategic blue print for the local industry

• Advanced Management Program (Corporate Strategy & Finance) from Stanford-NUS and a Bachelors degree in Biomedical Engineering (Gold Medalist) from Bombay University.